A radiobiological model of metastatic burden reduction for molecular radiotherapy: application to patients with bone metastases

Skeletal tumour burden is a biomarker of prognosis and survival in cancer patients. This study proposes a novel method based on the linear quadratic model to predict the reduction in metastatic tumour burden as a function of the absorbed doses delivered from molecular radiotherapy treatments. The ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Denis-Bacelar, Ana M, Chittenden, Sarah J, Murray, Iain, Divoli, Antigoni, Ralph McCready, V, Dearnaley, David P, O’Sullivan, Joe M, Johnson, Bernadette, Flux, Glenn D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOP Publishing 2017
Materias:
Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5953197/
https://www.ncbi.nlm.nih.gov/pubmed/28291739
http://dx.doi.org/10.1088/1361-6560/aa5e6f

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5953197/
https://www.ncbi.nlm.nih.gov/pubmed/28291739
http://dx.doi.org/10.1088/1361-6560/aa5e6f

Ejemplares similares